Intravenous immunoglobulin G use in patients with chronic inflammatory demyelinating polyneuropathy: An uncommon cause of drug-induced discoid lupus erythematosus.
Publication/Presentation Date
8-1-2019
Abstract
Drug-induced chronic cutaneous lupus erythematosus, or drug-induced discoid lupus erythematosus, is a rare cutaneous phenomenon. Various medications have been associated with drug-induced discoid lupus erythematosus including fluorouracile agents, especially tegafur and uraciltegafur, and TNF-α antagonists such as infliximab or etanercept. Recent literature has described a case series of six patients receiving IgG immunoglobulin for chronic inflammatory demyelinating polyneuropathy with subsequent presentations of discoid lupus erythematosus. We present a patient with chronic inflammatory demyelinating polyneuropathy who developed discoid lupus erythematosus secondary to IgG immunoglobulin.
Volume
60
Issue
3
First Page
208
Last Page
208
ISSN
1440-0960
Published In/Presented At
Jennings, T., Ahmed, S., Aphale, A., Lee, J., & Valdes-Rodriguez, R. (2019). Intravenous immunoglobulin G use in patients with chronic inflammatory demyelinating polyneuropathy: An uncommon cause of drug-induced discoid lupus erythematosus. The Australasian journal of dermatology, 60(3), e208–e210. https://doi.org/10.1111/ajd.12998
Disciplines
Medicine and Health Sciences
PubMedID
30734274
Department(s)
Department of Pathology and Laboratory Medicine
Document Type
Article